SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-220561
Filing Date
2022-08-15
Accepted
2022-08-15 07:23:31
Documents
74
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d383218d10q.htm   iXBRL 10-Q 2197811
2 EX-31.1 d383218dex311.htm EX-31.1 10015
3 EX-31.2 d383218dex312.htm EX-31.2 10014
4 EX-32.1 d383218dex321.htm EX-32.1 4719
5 EX-32.2 d383218dex322.htm EX-32.2 4273
  Complete submission text file 0001193125-22-220561.txt   7599640

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA roiv-20220630.xsd EX-101.SCH 56475
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE roiv-20220630_cal.xml EX-101.CAL 43845
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE roiv-20220630_def.xml EX-101.DEF 346154
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE roiv-20220630_lab.xml EX-101.LAB 397281
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE roiv-20220630_pre.xml EX-101.PRE 385033
68 EXTRACTED XBRL INSTANCE DOCUMENT d383218d10q_htm.xml XML 1098523
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-40782 | Film No.: 221162318
SIC: 2834 Pharmaceutical Preparations